Dallah Healthcare Company (4004.SR)
SAR 125.2
(-2.19%)
SAR 125.2
(-2.19%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.34 Billion SAR | -13.43% |
| 2022 | 1.55 Billion SAR | 13.14% |
| 2021 | 1.37 Billion SAR | 14.26% |
| 2020 | 1.2 Billion SAR | 42.45% |
| 2019 | 844.85 Million SAR | 50.16% |
| 2018 | 562.63 Million SAR | 22.77% |
| 2017 | 458.28 Million SAR | 41.87% |
| 2016 | 323.02 Million SAR | 31.6% |
| 2015 | 245.45 Million SAR | 445.45% |
| 2014 | 45 Million SAR | 0.0% |
| 2013 | - SAR | 0.0% |
| 2012 | - SAR | 0.0% |
| 2011 | - SAR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 1.2 Billion SAR | -3.54% |
| 2024 Q1 | 1.3 Billion SAR | -3.26% |
| 2023 Q4 | 1.34 Billion SAR | -2.12% |
| 2023 FY | 1.34 Billion SAR | -13.43% |
| 2023 Q3 | 1.37 Billion SAR | -4.02% |
| 2023 Q1 | 1.49 Billion SAR | -3.81% |
| 2023 Q2 | 1.43 Billion SAR | -4.19% |
| 2022 Q4 | 1.55 Billion SAR | 5.25% |
| 2022 Q1 | 1.4 Billion SAR | 2.29% |
| 2022 Q3 | 1.47 Billion SAR | 10.29% |
| 2022 FY | 1.55 Billion SAR | 13.14% |
| 2022 Q2 | 1.34 Billion SAR | -4.72% |
| 2021 Q3 | 1.1 Billion SAR | 2.01% |
| 2021 Q1 | 1.17 Billion SAR | -2.45% |
| 2021 FY | 1.37 Billion SAR | 14.26% |
| 2021 Q2 | 1.07 Billion SAR | -8.01% |
| 2021 Q4 | 1.37 Billion SAR | 24.82% |
| 2020 Q1 | 862.3 Million SAR | 2.07% |
| 2020 Q2 | 903.16 Million SAR | 4.74% |
| 2020 Q3 | 834.53 Million SAR | -7.6% |
| 2020 FY | 1.2 Billion SAR | 42.45% |
| 2020 Q4 | 1.2 Billion SAR | 44.21% |
| 2019 Q2 | 856.2 Million SAR | 41.37% |
| 2019 FY | 844.85 Million SAR | 50.16% |
| 2019 Q4 | 844.85 Million SAR | 0.63% |
| 2019 Q3 | 839.57 Million SAR | -1.94% |
| 2019 Q1 | 605.65 Million SAR | 7.64% |
| 2018 Q1 | 467.58 Million SAR | 2.03% |
| 2018 FY | 562.63 Million SAR | 22.77% |
| 2018 Q4 | 562.63 Million SAR | 3.39% |
| 2018 Q3 | 544.17 Million SAR | 7.34% |
| 2018 Q2 | 506.97 Million SAR | 8.43% |
| 2017 Q3 | 379.24 Million SAR | 13.14% |
| 2017 Q1 | 314.15 Million SAR | -2.75% |
| 2017 Q4 | 458.28 Million SAR | 20.84% |
| 2017 FY | 458.28 Million SAR | 41.87% |
| 2017 Q2 | 335.18 Million SAR | 6.7% |
| 2016 Q3 | 340.62 Million SAR | 7.78% |
| 2016 FY | 323.02 Million SAR | 31.6% |
| 2016 Q2 | 316.03 Million SAR | 19.56% |
| 2016 Q1 | 264.31 Million SAR | 7.69% |
| 2016 Q4 | 323.02 Million SAR | -5.17% |
| 2015 Q3 | 130.79 Million SAR | -12.02% |
| 2015 Q4 | 245.45 Million SAR | 87.67% |
| 2015 FY | 245.45 Million SAR | 445.45% |
| 2015 Q1 | 166.54 Million SAR | 270.09% |
| 2015 Q2 | 148.66 Million SAR | -10.73% |
| 2014 Q2 | - SAR | 0.0% |
| 2014 FY | 45 Million SAR | 0.0% |
| 2014 Q1 | - SAR | 0.0% |
| 2014 Q3 | 50 Million SAR | 0.0% |
| 2014 Q4 | 45 Million SAR | -10.0% |
| 2013 Q1 | - SAR | 0.0% |
| 2013 Q2 | - SAR | 0.0% |
| 2013 Q3 | - SAR | 0.0% |
| 2013 FY | - SAR | 0.0% |
| 2013 Q4 | - SAR | 0.0% |
| 2012 FY | - SAR | 0.0% |
| 2012 Q4 | - SAR | 0.0% |
| 2012 Q3 | - SAR | 0.0% |
| 2011 FY | - SAR | 0.0% |
| 2011 Q4 | - SAR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Mouwasat Medical Services Company | 518.83 Million SAR | -159.593% |
| National Medical Care Company | 261.99 Million SAR | -414.073% |
| Al Hammadi Company For Development and Investment | 271.86 Million SAR | -395.405% |
| Middle East Healthcare Company | 1.31 Billion SAR | -2.789% |
| Dr. Sulaiman Al Habib Medical Services Group Company | 4.81 Billion SAR | 72.0% |
| Canadian General Medical Center Complex Company | 4.34 Million SAR | -30880.857% |
| Arabian International Healthcare Holding Company | 25 Million SAR | -5287.42% |
| Future Care Trading Co. | 1.74 Million SAR | -77241.139% |
| Naba Alsaha Medical Services Company | 34.31 Million SAR | -3825.182% |
| Lana Medical Co. | 3.65 Million SAR | -36775.252% |
| Al-Modawat Specialized Medical Co. | 1.92 Million SAR | -69874.452% |